All the charts have a disclaimer saying : chart based on predicted 20nm performance. While maybe the concept it proven at 60nm, seems they still really need 20nm to be interesting.
But good to see people coming around to the reality that beyond 5/6 there will be more development, likely years more. This is not for sale.
- Forums
- ASX - By Stock
- 4DS
- Ann: 4DS Australian Open Briefings Presentation
Ann: 4DS Australian Open Briefings Presentation, page-47
-
-
- There are more pages in this discussion • 384 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add 4DS (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.8¢ |
Change
-0.002(2.22%) |
Mkt cap ! $155.1M |
Open | High | Low | Value | Volume |
9.0¢ | 9.1¢ | 8.8¢ | $255.0K | 2.855M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 201205 | 8.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.9¢ | 20000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3695 | 0.093 |
1 | 32298 | 0.090 |
1 | 11998 | 0.089 |
5 | 201207 | 0.088 |
8 | 774567 | 0.087 |
Price($) | Vol. | No. |
---|---|---|
0.086 | 47993 | 1 |
0.089 | 20000 | 1 |
0.090 | 313381 | 2 |
0.091 | 11445 | 1 |
0.092 | 683892 | 3 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
4DS (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online